Qiao-Li Wang
-
- Pancreatic and Hepatic Oncology Research 7
- Cancer Risks and Factors 4
-
- Herpesvirus Infections and Treatments 9
-
- Gastric Cancer Management and Outcomes 5
-
- RNA modifications and cancer 4
- Protein Degradation and Inhibitors 4
-
- Esophageal Cancer Research and Treatment 4
- Esophageal and GI Pathology 4
Qiao-Li Wang
72 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 124
- Oncology 222
- Cancer Research 115
- Biological Psychiatry 17
- Epidemiology 232
- Virology 28
Countries citing papers authored by Qiao-Li Wang
This map shows the geographic impact of Qiao-Li Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiao-Li Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiao-Li Wang more than expected).
Fields of papers citing papers by Qiao-Li Wang
This network shows the impact of papers produced by Qiao-Li Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiao-Li Wang. The network helps show where Qiao-Li Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qiao-Li Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 10 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 25 | |
| 11 | 2022 | 5 | |
| 12 | 2021 | 16 | |
| 13 | 2020 | 5 | |
| 14 | 2020 | 2 | |
| 15 | 2020 | 2 | |
| 16 | 2020 | 16 | |
| 17 | 2017 | 11 | |
| 18 | 2017 | 10 | |
| 19 | 2013 | 9 | |
| 20 | 2011 | 31 |
About Qiao-Li Wang
Qiao-Li Wang is a scholar working on Oncology, Virology, Epidemiology, Gastroenterology and Immunology, having authored 82 papers that have together received 1.1k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (9 papers), Pancreatic and Hepatic Oncology Research (7 papers), Gastric Cancer Management and Outcomes (5 papers), RNA modifications and cancer (4 papers), Cancer Risks and Factors (4 papers), Esophageal Cancer Research and Treatment (4 papers), Protein Degradation and Inhibitors (4 papers) and Esophageal and GI Pathology (4 papers). The work is most often cited by research in Oncology (222 citations), Cancer Research (115 citations), Biological Psychiatry (17 citations), Epidemiology (232 citations) and Virology (28 citations). Qiao-Li Wang has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Yifei Wang, Jesper Lagergren, Yangfei Xiang, Kaio Kitazato, Shao-Hua Xie, Meigong Zhong, Zhe Ren, Fujun Jin, Kai Zheng and Shao‐Hua Xie. Their work appears in journals such as PLoS ONE, JNCI Journal of the National Cancer Institute, Nature Communications, European Journal of Pharmacology and Journal of Fungi.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.